About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Psychiatrie Pro Praxi
›
top-articles
Psychiatrie Pro Praxi
0.1
(top 100%)
impact factor
210
(top 50%)
papers
57
(top 100%)
citations
3
(top 100%)
h
-index
0.1
(top 100%)
extended IF
211
all documents
60
doc citations
5
(top 100%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Vortioxetine: a review of new antidepressant
Psychiatrie Pro Praxi
2016
9
2
Results of therapeutically castration by paraphiliac sexual offenders
Psychiatrie Pro Praxi
2016
3
3
Pregabalin in the treatment of generalized anxiety disorder
Psychiatrie Pro Praxi
2017
3
4
Pathologic sexual aggression in practice
Psychiatrie Pro Praxi
2017
3
5
Research of new drugs for Alzheimer's disease
Psychiatrie Pro Praxi
2017
2
6
Group CBT therapy for patients with anxiety and depressive disorders experience from practice
Psychiatrie Pro Praxi
2016
2
7
News in gerontopsychiatry
Psychiatrie Pro Praxi
2019
2
8
Transformations of addiction treatment - therapy without power (powerlessness)
Psychiatrie Pro Praxi
2020
2
9
Schizo-obsessive symptoms
Psychiatrie Pro Praxi
2020
2
10
Multidisciplinary approach and its importance for the mental health of children and adolescents not only in eating disorder
Psychiatrie Pro Praxi
2021
1
11
Effect of coronavirus epidemic on development and treatment of eating disorders in childhood and adolescence
Psychiatrie Pro Praxi
2021
1
12
What prevents more successful pharmacological treatment of depressive disorder?
Psychiatrie Pro Praxi
2019
1
13
Monitoring of adverse events and safety of antidepressants
Psychiatrie Pro Praxi
2019
1
14
Therapeutic drug monitoring in psychiatry - possibilities and use in practice
Psychiatrie Pro Praxi
2016
1
15
Some issues of antidepressant efficacy and tolerability relevant for routine clinical practice
Psychiatrie Pro Praxi
2016
1
16
Psychosocial risk factors in schizophrenia
Psychiatrie Pro Praxi
2016
1
17
Aripiprazole in the treatment of bipolar disorder - its use in the clinical practice
Psychiatrie Pro Praxi
2016
1
18
Indicators of quality of care and their use in psychiatry
Psychiatrie Pro Praxi
2016
1
19
A new nomenclature for psychotropic agents (Neuroscience-based Nomenclature)
Psychiatrie Pro Praxi
2016
1
20
Practical risk management in psychiatric care: benefits of root cause analysis and failure modes and effects analysis and their practical use
Psychiatrie Pro Praxi
2017
1
21
Case report of a patient with Huntington's disease
Psychiatrie Pro Praxi
2017
1
22
Bio-psycho-social approach offers more understanding
Psychiatrie Pro Praxi
2017
1
23
Treatment of depressive disorder with cognitive dysfunction
Psychiatrie Pro Praxi
2017
1
24
Rorschach method as a direct Indicator of the particular drug Choice in patients with affective disorders
Psychiatrie Pro Praxi
2017
1
25
Novel trends in treatment of obsessive-compulsive disorder
Psychiatrie Pro Praxi
2017
1
26
Consumption of addictive sedatives and hypnotics in the Czech Republic and addiction on these medicinesfrom the consiliary psychiatric view
Psychiatrie Pro Praxi
2017
1
27
Pharmacotherapy of Alzheimer disease and neuropsychiatric symptoms of dementia
Psychiatrie Pro Praxi
2018
1
28
Pharmacotherapy of Alzheimer disease and neuropsychiatric symptoms of dementia
Psychiatrie Pro Praxi
2018
1
29
Psychiatric inpatient suicide in the Czech Republic
Psychiatrie Pro Praxi
2018
1
30
Novel treatment possibilities in depression and schizophrenia
Psychiatrie Pro Praxi
2018
1
31
Off‑label treatment with antidepressants and antipsychotics
Psychiatrie Pro Praxi
2019
1
32
Maintenance treatment of schizophrenia with long‑acting injectable antipsychotics - work with patients and their family members
Psychiatrie Pro Praxi
2019
1
33
Postpartum mental disorders: specifics and pharmacotherapy. Part One: depression, anxiety disorders, sleep disorders, and ADHD
Psychiatrie Pro Praxi
2019
1
34
Agomelatin - tolerance with great effect
Psychiatrie Pro Praxi
2019
1
35
Mental health and immunity
Psychiatrie Pro Praxi
2020
1
36
Alzheimer's disease, appeal to public health
Psychiatrie Pro Praxi
2019
1
37
Trazodone once‑daily in depression
Psychiatrie Pro Praxi
2019
1
38
Mobbing in workplace: mechanisms and condsequences
Psychiatrie Pro Praxi
2021
1
39
Survey on the topic: Children at risk of pornography and online sexual aggressors
Psychiatrie Pro Praxi
2021
1
40
Group CBT for patients with anxiety disorders - reflection of further experience from practice
Psychiatrie Pro Praxi
2022
1
41
Minority stress in the perspective of health inequalities between heterosexual and non‑heterosexual people
Psychiatrie Pro Praxi
2022
1
42
Diagnosing major sleep disorders
Psychiatrie Pro Praxi
2021
0
43
Lurasidon in the treatment of the patient with paranoid schizophrenia previously treated by combination of atypical antipsychotics: case report
Psychiatrie Pro Praxi
2021
0
44
Confidentiality obligation of health care professionals and its breaking under the current legislation - Part 3
Psychiatrie Pro Praxi
2021
0
45
Schizophrenia and intestinal microbiome
Psychiatrie Pro Praxi
2021
0
46
Factitious disorder: overview and case report
Psychiatrie Pro Praxi
2021
0
47
Covid - recommendations how to cope with stressful time. Mental conditions related to SARS-CoV-2
Psychiatrie Pro Praxi
2021
0
48
The relationship between gut microbiota and behavior
Psychiatrie Pro Praxi
2021
0
49
Cyclothymia
Psychiatrie Pro Praxi
2021
0
50
Effect of fish oil food supplement consumption on omega 3 index and selected cognitive functions in actively sport pupils in the second stage of primary schools
Psychiatrie Pro Praxi
2021
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.